OPPENHEIMER & CO INC NVCT — NUVECTIS PHARMA INC

Ownership history in OPPENHEIMER & CO INC  ·  6 quarters on record

AI Ownership Summary

OPPENHEIMER & CO INC reported NUVECTIS PHARMA INC (NVCT) in 6 quarterly 13F filings from 2024 Q4 through 2026 Q1. Peak portfolio weight reached 0.01% in 2025 Q4. The latest visible filing shows NVCT at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this NVCT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was OPPENHEIMER & CO INC's position in NUVECTIS PHARMA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

NVCT was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

NVCT stock page OPPENHEIMER & CO INC fund profile OPPENHEIMER & CO INC full holdings
How OPPENHEIMER & CO INC held NVCT — position size vs. price
% of Fund (quarterly)    NVCT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 73,566 — 0% 0.01% $569K 2026-04-24 $8.90
2025 Q4 ADDED — — — 73,566 +4,500 +6.5% 0.01% $555K 2026-02-02 $8.36
2025 Q3 UNCHANGED — — — 69,066 — 0% 0.01% $416K 2025-11-06 $5.67
2025 Q2 ADDED — — — 69,066 +28,066 +68.5% 0.01% $516K 2025-07-31 $6.96
2025 Q1 ADDED — — — 41,000 +16,000 +64.0% 0.01% $401K 2025-04-23 $10.41
2024 Q4 INITIATED — — — 25,000 — — 0.00% $135K 2025-02-05 $7.15

🏢 Other funds also holding NVCT

As of 2026 Q1 — sorted by position size

IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 2.04% Occam Crest Management LP 1.91% BALDWIN WEALTH PARTNERS LLC/MA 3Y 7Y 0.21% FORBES J M & CO LLP 3Y 7Y 0.04% Austin Wealth Management, LLC 0.03% Avalon Trust Co 3Y 0.01% EverSource Wealth Advisors, LLC 3Y 0.01% NATIONS FINANCIAL GROUP INC, /IA/ /ADV 3Y 7Y 0.01% MARTINGALE ASSET MANAGEMENT L P 3Y 7Y 0.0% NBC SECURITIES, INC. 0.0%

FAQ About OPPENHEIMER & CO INC and NVCT

These are the practical questions this page is built to answer before you even open the full history table.

How long has OPPENHEIMER & CO INC reported owning NVCT?

OPPENHEIMER & CO INC reported NVCT across 6 quarterly 13F filings, from 2024 Q4 through 2026 Q1.

What was the largest reported NVCT position in OPPENHEIMER & CO INC's portfolio?

The largest reported portfolio weight for NVCT was 0.01% in 2025 Q4.

What is the latest reported NVCT position on this page?

The most recent filing on this page is 2026 Q1, when OPPENHEIMER & CO INC reported 73,566 shares, equal to 0.01% of portfolio, with an estimated market value of $569K.

What does the chart on this NVCT ownership page compare?

The chart compares OPPENHEIMER & CO INC's quarterly NVCT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did OPPENHEIMER & CO INC time their NVCT position?

Based on 13F filing dates vs. subsequent NVCT price moves, OPPENHEIMER & CO INC correctly timed 2 out of 4 reported position changes (50%). The annualised alpha on NVCT relative to SPY over the holding period was +3.2%.

← Back to OPPENHEIMER & CO INC Holdings